Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 75 percent increase over losses of $(0.28) per share from the same period last year.
Morgan Stanley Maintains Equal-Weight on National Storage, Raises Price Target to $52
Morgan Stanley analyst Ronald Kamdem maintains National Storage (NYSE:NSA) with a Equal-Weight and raises the price target from $49 to $52.
